A Randomized, Doubleblind, Vehicle-controlled, Parallel-group Trial to Assess the Efficacy, Safety and Tolerability of P-3073 for Topical Treatment of Nail Psoriasis

Trial Profile

A Randomized, Doubleblind, Vehicle-controlled, Parallel-group Trial to Assess the Efficacy, Safety and Tolerability of P-3073 for Topical Treatment of Nail Psoriasis

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 14 Jul 2017

At a glance

  • Drugs Calcipotriol (Primary)
  • Indications Nail disorders; Psoriasis
  • Focus Therapeutic Use
  • Sponsors Polichem
  • Most Recent Events

    • 28 Mar 2017 Planned initiation date changed from 24 Mar 2017 to 15 May 2017.
    • 28 Mar 2017 Planned initiation date changed from 24 Mar 2017 to 15 May 2017.
    • 09 Mar 2017 Status changed from planning to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top